Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 5Completed 3Active not recruiting 2Unknown 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1

Conditions

Ovarian Neoplasms 1Neoplasm Metastasis 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Tumor Burden × Clear all
NCT04257162 2025-09-09

HER2-PREDICT

SOLTI Breast Cancer Research Group

Phase NA Active not recruiting
180 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05953883 2025-03-04

PROGENITOR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Active not recruiting
24 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡